On March 21, 2024, Fate Therapeutics, Inc closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.555 USD | +0.99% | -3.65% | -4.68% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.95% | 401M | |
+9.80% | 118B | |
+10.61% | 106B | |
-10.90% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.59% | 15.97B | |
+6.84% | 14.03B | |
+17.61% | 11.67B |
- Stock Market
- Equities
- FATE Stock
- News Fate Therapeutics, Inc.
- Fate Therapeutics, Inc. announced that it has received $19.996366 million in funding from Redmile Group, LLC